Reference | Outcomes | Treatments | Population | Database | Results |
---|---|---|---|---|---|
Van Aalderen et al. [67] | Clinical | BDP pMDI St versus EF Initiation Step-up Vs LABA | Children 5–11 | UK (CPRD) US (Optuminsight) | EF > St EF = adding LABA |
Price et al. [70] | Clinical | BDP pMDI St versus EF Initiation Switch | 12–80 | UK GPRD CPRD | EF > St |
Price et al. [71] | Clinical | pMDI St FP versus EF BDP Initiation Step-up | 5–60 | UK GPRD | EF ≥ St at lower doses |
Barnes et al. [40] | Clinical | BDP pMDI St versus EF Initiation Step-up | 5–60 | UK GPRD | EF > St |
Martin et al. [68] | C-E | BDP/FP pMDI St versus EF Initiation | 12–60/12–80 | UK/US | EF dominant |
Colice et al. [69] | C-E | pMDI St FP versus EF BDP Initiation Step-up | 12–80 | UK/US | EF ≥ St at lower doses and costs |
Price et al. [32] | C-E | St FP-SAL versus EF BDP-FOR | 18–80 | UK GPRD CPRD | EF ≥ St at lower doses EF dominant |